Incyte

Incyte

Yahoo Finance • yesterday

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_asset%3Aful... Full story

Yahoo Finance • 4 days ago

Incyte to Report Third Quarter Financial Results

WILMINGTON, Del., October 08, 2026--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Thursday, October 29, 2026. The schedule f... Full story

Yahoo Finance • 7 days ago

Stock futures rise after Nasdaq hits record high

[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Stock index futures were higher on Tuesday, a day after the Nasdaq Composite touched a record high while investors looked ahead to trade data and comments from Federal Res... Full story

Yahoo Finance • 15 days ago

At a glance: stocks gapping up premarket

[Wall Street New York City] aluxum/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-up moves before the bell on Monday. Stock index futures came under immediate pressure on Monday after President Donald Trump rej... Full story

Yahoo Finance • 22 days ago

Specialised Therapeutics to commercialize Incyte’s Opzelura in Australia

[Partnership word near puzzle pieces. Teamwork concept. Strategic cooperation. Reliable partner. 3d render] Independent biopharmaceutical company Specialised Therapeutics announced an expansion of its partnership [https://seekingalpha.com... Full story

Yahoo Finance • 22 days ago

Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia

SINGAPORE, Sept. 20, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) today announced an expansion of its existing partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ: I... Full story

Yahoo Finance • 23 days ago

Robinhood Soars, SpaceX Orbits Entry: Five Stocks Near Buy Points

Robinhood stock surged in an end-of-week crypto rally. SpaceX is testing an aggressive entry. They lead five stocks near buy points. Continue Reading... Full story

Yahoo Finance • 28 days ago

INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?

Shares of Incyte INCY have rallied 23% year to date compared with the industry's growth of 5.2%. The stock has also outperformed the medical sector and the S&P 500 Index during this time frame. Much of this rally came after the company re... Full story

Yahoo Finance • last month

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Former Incyte Executive Brings Extensive Oncology, Corporate Strategy, Business Development and Medical Affairs Experience MORRISTOWN, N.J., Sept. 10, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage onco... Full story

Yahoo Finance • last month

Stock futures mixed as traders look ahead to wholesale inflation report

[Wall Street street sign in Manhattan financial district] Alexey_Fedoren Stock index futures were mixed on Thursday as traders looked ahead to the wholesale inflation report. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) +0.1... Full story

Yahoo Finance • last month

Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock Picks

In a recent interview on CNBC's Halftime Report, Josh Brown, CEO of Ritholtz Wealth Management, highlighted Incyte (NASDAQ: INCY) and Biogen (NASDAQ: BIIB) as two of his "Best Stocks in the Market." Brown said he wanted to focus on stocks... Full story

Yahoo Finance • last month

AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?

The pharmaceutical market is currently defined by a race to replace aging blockbusters with next-generation therapies. Deciding whether to buy AbbVie Inc (NYSE:ABBV) or Eli Lilly and Co (NYSE:LLY) requires weighing different growth engines... Full story

Yahoo Finance • last month

Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report?

A month has gone by since the last earnings report for uniQure (QURE). Shares have added about 17.5% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leading up to... Full story

Yahoo Finance • 2 months ago

Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD?

Spyre Therapeutics SYRE expanded its inflammatory-disease strategy in August with SPY772 and the phase II SKYLIGHT study in hidradenitis suppurativa, or HS. The move takes its combination approach into a new disease area beyond inflammator... Full story

Yahoo Finance • 2 months ago

Stock index futures largely flat after S&P 500 closes at record high

[Wall Street New York stock exchange stock market] alexsl Stock index futures were muted on Friday after the S&P 500 closed at a record high in the previous session. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.12%, S&P 5... Full story

Yahoo Finance • 2 months ago

1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds

1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds When Wall Street turns bearish on a stock, it's worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms wi... Full story

Yahoo Finance • 2 months ago

US Stock Market Today: S&P 500 Futures Slip As Fed Rate Uncertainty Builds

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. The Morning Bull - US Market Morning Update Wednesday, Jul, 29 2026 US stock futures are mixed in early Tuesday trade, with broad... Full story

Yahoo Finance • 3 months ago

Incyte forecasts $5.130B-$5.260B 2026 net sales as Opzelura guidance rises to $1.050B-$1.1B after CMS settlement

Earnings Call Insights: Incyte Corporation (INCY) Q2 2026 MANAGEMENT VIEW * "At the start of the year, we laid out a plan to move Incyte from reliance on a cornerstone product to a company with multiple growth drivers," William Meury (... Full story

Yahoo Finance • 3 months ago

Incyte Q2 Revenue Jumps 38%, Raises FY26 Sales Guidance

(RTTNews) - Incyte Corp. (INCY) on Tuesday reported an increase in second-quarter earnings and revenue, driven by strong growth across its commercial portfolio. The company also raised its full-year 2026 sales guidance. Second-quarter net... Full story

Yahoo Finance • 3 months ago

Incyte Non-GAAP EPS of $3.09 beats by $0.94, revenue of $1.67B beats by $180M

* Incyte press release [https://seekingalpha.com/pr/20596936-incyte-reports-second-quarter-2026-financial-results-and-provides-business-updates] (INCY [https://seekingalpha.com/symbol/INCY]): Q2 Non-GAAP EPS of $3.09 beats by $0.94. *... Full story